Danielle M. Burgenske

Temozolomide Sensitizes MGMT-Deficient Tumor Cells to ATR Inhibitors

Christopher Jackson, Seth Noorbakhsh, Ranjini K. Sundaram et al. · Cancer Research · 2019 · 93 citations · Full text

Medicine, Oncology, Pharmacology +15

Molecular profiling of long-term IDH-wildtype glioblastoma survivors

Danielle M. Burgenske, Jie Yang, Paul A. Decker et al. · Neuro-Oncology · 2019 · 81 citations · Full text

Medicine, Molecular Genetics, Oncology +15

Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastoma

Bianca M. Marin, Kendra A. Porath, Sonia Jain et al. · Neuro-Oncology · 2021 · 81 citations · Full text

Medicine, Oncology, Pharmacology +17

Brain Distribution of Berzosertib: An Ataxia Telangiectasia and Rad3-Related Protein Inhibitor for the Treatment of Glioblastoma

Surabhi Talele, Wenjuan Zhang, Danielle M. Burgenske et al. · Journal of Pharmacology and Experimental Therapeutics · 2021 · 45 citations · Full text

Medicine, Oncology, Pharmacology +17

Persistent Mitochondrial Hyperfusion Promotes G2/M Accumulation and Caspase-Dependent Cell Death

Laura M. Westrate, Aaron Sayfie, Danielle M. Burgenske et al. · PLoS ONE · 2014 · 41 citations · Full text

Life Sciences, Cell Biology, Oncology +17